“Empowering Vietnam’s Future: Tether and Medoo Join Forces to Launch Blockchain Academy”

Tether and Medoo Join Forces to Establish Blockchain Academy in Vietnam Introduction Tether and Medoo have recently announced a strategic collaboration to launch a Blockchain Academy in Vietnam. This initiative aims to boost blockchain education and adoption in the region, providing essential knowledge and skills to individuals interested in this rapidly growing technology. Why Vietnam?…

Read More

Unlocking the Potential: JPMorgan Predicts Bitcoin and Ethereum Need a Fresh Spark for Increased Retail Interest in the Cryptocurrency Market

The Need for a New Catalyst in the Cryptocurrency Market Overview According to a new JPMorgan report, the cryptocurrency market needs a new catalyst to drive the sector forward and spark “enhanced retail engagement” to reverse August’s market downtrend. JPMorgan analysts, led by Kenneth Worthington, highlighted the broader challenges facing the crypto ecosystem, stating, “Overall,…

Read More

Uncovering the Truth: Pomerantz Law Firm Investigates Claims Against Charles Schwab Corporation on Behalf of Investors

Investigation into The Charles Schwab Corporation New York, July 26, 2022 (GLOBE NEWSWIRE) – Pomerantz Law Firm Investigating Claims on Behalf of Investors Pomerantz LLP, a well-known law firm based in New York, is currently conducting an investigation on behalf of investors of The Charles Schwab Corporation (NYSE: SCHW). Investors who have purchased shares of…

Read More

Zealand Pharma Announces Boehringer’s FDA Breakthrough Therapy Designation and Phase III Trials for Survodutide in MASH

Zealand Pharma Announces Boehringer’s U.S. FDA Breakthrough Therapy Designation for Survodutide Company Announcement – No. 47 / 2024 Breakthrough Therapy Designation and Phase III Trials Zealand Pharma has announced that Boehringer has received U.S. FDA Breakthrough Therapy designation and has initiated two Phase III trials for survodutide. This designation is for the treatment of adults…

Read More